Related Experiment Videos
Endothelial dysfunction and decreased exercise tolerance in interferon-alpha therapy in chronic hepatitis C: relation
B Takase1, A Uehata, T Fujioka
1National Defense Medical College, Internal Medicine-1, Research Center, Tokorozawa, Saitama, Japan.
Clinical Cardiology
|April 17, 2001
Summary
Interferon-alpha therapy impairs endothelial function and exercise tolerance in hepatitis C patients. This suggests endothelial function plays a role in exercise hyperemia, impacting peripheral circulation.
Area of Science:
- Cardiovascular Medicine
- Hepatology
- Pharmacology
Background:
- Interferon-alpha (IFN) therapy has been linked to reversible endothelial dysfunction in hepatitis C patients.
- Endothelium-derived nitric oxide is crucial for exercise-induced blood flow in limbs.
Purpose of the Study:
- To confirm IFN's effect on endothelial function in humans.
- To investigate the role of endothelial function in exercise hyperemia.
Main Methods:
- 10 chronic hepatitis C patients underwent exercise treadmill testing.
- Brachial artery flow-mediated dilation (FMD) and glyceryl-trinitrate-induced dilation (GTN-D) were measured before and after 4 weeks of IFN therapy.
- Ultrasound assessed endothelium-dependent (FMD) and independent (GTN-D) vasodilation.
Main Results:
- IFN therapy significantly decreased FMD and exercise tolerance.
- Endothelium-independent GTN-D was not affected by IFN.
- Decreased FMD correlated strongly with reduced exercise tolerance, indicating peripheral circulation impact.
Conclusions:
- IFN impairs endothelial function and exercise tolerance in hepatitis C patients.
- Endothelial function appears to be involved in human exercise hyperemia.
- Findings highlight the impact of IFN on vascular health and exercise capacity.